| All patients | With T2DM | No T2DM | P value |
---|---|---|---|---|
(n = 1152) | (n = 155) | (n = 997) |  | |
Male, n | 786 (68%) | 115 (74%) | 671 (67%) | 0.09 |
Age (years) | 48 ± 14 | 55 ± 12 | 47 ± 14 | < 0.001 |
BMI (kg/m2) | 24.0 ± 4.1 | 24.5 ± 3.9 | 23.9 ± 4.1 | 0.07 |
SBP (mmHg) | 116 ± 17 | 116 ± 19 | 115 ± 17 | 0.73 |
DBP (mmHg) | 76 ± 13 | 76 ± 14 | 76 ± 13 | 0.88 |
NYHA class, n | Â | Â | Â | 0.003 |
 I | 137 (12%) | 7 (5%) | 130 (13%) |  |
 II | 451 (39%) | 55 (36%) | 396 (40%) |  |
 III | 420 (37%) | 72 (47%) | 348 (35%) |  |
 IV | 144 (13%) | 21 (14%) | 123 (12%) |  |
Hypertension, n | 266 (23%) | 57 (37%) | 209 (21%) | < 0.001 |
Atrial fibrillation, n | 207 (18%) | 48 (31%) | 159 (16%) | < 0.001 |
LBBB, n | 130 (11%) | 17 (11%) | 113 (11%) | 0.89 |
Smoking, n | 473 (41%) | 75 (48%) | 398 (40%) | 0.05 |
Alcohol, n | 318 (28%) | 49 (32%) | 269 (27%) | 0.23 |
ACEI/ARB/ARNI, n | 943 (82%) | 133 (86%) | 810 (81%) | 0.17 |
β-blockers, n | 950 (83%) | 131 (85%) | 819 (82%) | 0.47 |
MRA, n | 841 (73%) | 121 (78%) | 720 (72%) | 0.13 |
Diuretics, n | 785 (68%) | 118 (76%) | 667 (67%) | 0.02 |
Digoxin, n | 250 (22%) | 45 (29%) | 205 (21%) | 0.02 |
Anticoagulants, n | 164 (14%) | 42 (27%) | 122 (12%) | < 0.001 |
SGLT2i, n | 89 (8%) | 37 (24%) | 52 (5%) | < 0.001 |
Biguanides, n | 54 (5%) | 54 (35%) | 0 | - |
a-Glucosidase inhibitor, n | 37 (3%) | 37 (24%) | 0 | - |
Insulin, n | 29 (3%) | 29 (19%) | 0 | - |